ATF6 divergent transcript (ATF6-DT)

ATF6-DT (ATF6 divergent transcript) appears to refer to a non-coding RNA (likely a long non-coding RNA) transcribed in the region near the ATF6 gene but on the opposite strand (divergent transcripts are transcribed in the opposite direction from a shared promoter or genomic locus). There is no evidence in the major literature or target databases that ATF6-DT itself is a well-defined therapeutic target, protein, or characterized in signaling, receptor activity, or other molecular target activities. The canonical, well-characterized molecule is Activating transcription factor 6 (ATF6), which is a transmembrane transcription factor playing a central role in the unfolded protein response. No evidence was found that "ATF6 divergent transcript" is used as a molecular drug target, has biological function ascribed, or is considered a biomarker or disease driver. This entry may refer to a genomic artifact, uncharacterized lncRNA, or misinterpretation in target listings. If your intention was to refer to the protein ATF6 (Activating transcription factor 6, a key ER stress response transcription factor), search results provide abundant canonical and functional details for ATF6. However, for "ATF6 divergent transcript" specifically, there is insufficient information to classify it as a valid drug target or to populate most of the structured fields.

Other names

ATF6-DTATF6 divergent transcript

None